TREATMENT WITH THE CHIMERIC ANTI-IL-2Rα ANTIBODY BASILIXIMAB (SIMULECT®) AFFECTS BOTH THE IL-2 AND THE IL-15 SIGNALING PATHWAY AFTER CLINICAL KIDNEY TRANSPLANTATION

Autor:	Maud J.A.M. Boelaars-van Haperen, Iza C. van Riemsdijk, Willem Weimar, Jan N. M. IJzermans, Carla C. Baan
Rok vydání:	2000
Předmět:	Transplantation biology business.industry Basiliximab medicine.disease Interleukin 15 Immunology biology.protein Medicine Signal transduction Antibody business Kidney transplantation medicine.drug
Zdroj:	Transplantation. 69:S259
ISSN:	0041-1337
DOI:	10.1097/00007890-200004271-00570
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::03bb9d6ec325b8866c4efb32abe31b38 https://doi.org/10.1097/00007890-200004271-00570 Zobrazit plný text záznamu